短期饥饿通过重塑肝细胞癌肿瘤相关巨噬细胞增强抗PD-L1治疗
本研究在3种肝细胞癌小鼠模型、NCG小鼠和Rag2-KO小鼠中探讨短期饥饿(STS)能否增敏免疫治疗。STS通过诱导肿瘤相关巨噬细胞(TAM)向抗肿瘤表型转换、增强吞噬并激活CD8+ T细胞抗肿瘤免疫,从而延缓肿瘤进展;STS联合抗PD-1/L1可抑制肿瘤进展,且PD-L1联合STS疗效提高。机制上,TAM来源外泌体PD-L1(exoPD-L1)损害抗PD-1/L1疗效,STS通过调控果糖二磷酸酶1(FBP1)/Akt/Rab27a轴减少exoPD-L1分泌。
要点
- STS诱导TAM向抗肿瘤表型转换并增强CD8+ T细胞抗肿瘤免疫。
- STS联合抗PD-L1可抑制肿瘤进展并提高PD-L1疗效。
- STS通过FBP1/Akt/Rab27a轴减少TAM分泌exoPD-L1。
核心结论
- 本研究描述了STS的免疫调节作用,并为其作为肝细胞癌免疫治疗佐剂的应用提供了依据。
研究设计与样本
- 研究在3种肝细胞癌小鼠模型、NCG小鼠和Rag2-KO小鼠中开展。
主要发现
- STS通过诱导TAM向抗肿瘤表型转换、增强对肿瘤细胞的吞噬并刺激CD8+ T细胞后续抗肿瘤免疫来延缓肿瘤进展。
- STS联合抗PD-1/L1抑制肿瘤进展,且PD-L1联合STS时疗效提高。
- TAM来源的exoPD-L1损害抗PD-1/L1疗效,STS通过调控FBP1/Akt/Rab27a轴减少TAM分泌exoPD-L1。
- 使用2种脂质体递送系统和巨噬细胞过继转移调控FBP1/Akt/Rab27a轴可增强抗PD-L1应答。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Immune checkpoint inhibitors have revolutionized systemic HCC treatment. Nevertheless, numerous patients are refractory to immune checkpoint inhibitor therapy. It is currently unknown whether diet therapies such as short-term starvation (STS) combined with immune checkpoint inhibitors can be used to treat HCC. This study aimed to investigate whether STS could sensitize HCC tumors to immunotherapy. APPROACH AND RESULTS: STS was found to attenuate tumor progression by inducing tumor-associated macrophages (TAMs) to switch to an antitumoral phenotype, enhancing phagocytosis of tumor cells, and stimulating subsequent antitumor immunity of CD8 + T cells as demonstrated in 3 HCC mouse models, NCG mice, and Rag2-KO mice. Furthermore, STS combined with anti-programmed cell death 1/ligand 1 (anti-PD-1/L1) suppressed tumor progression, while the efficacy of PD-L1 was improved when combined with STS. Mechanistically, TAM-derived exosomal PD-L1 (exoPD-L1) impairs the efficacy of anti-PD-1/L1. STS attenuates exoPD-L1 secretion from TAM by regulating the fructose diphosphatase 1 (FBP1) /Akt/Rab27a axis. Modulating FBP1/Akt/Rab27a axis potentiates the anti-PD-L1 response using 2 liposomal delivery systems and macrophage adoptive transfer. CONCLUSIONS: This study describes the immunomodulatory effects of STS and provides a rationale for its application as an adjuvant in HCC immunotherapy.
引用
- Cheng K, Cai N, Yang X, et al. Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma. Hepatology. 2025. PMID: 39879585. doi:10.1097/HEP.0000000000001244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。